Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System
Obalon now has 22 patents issued in the U.S. and 31 patents issued internationally covering the Company’s proprietary Obalon Balloon System and 24 and 55 patent applications pending in the U.S. and international territories, respectively.
“These patents add to the intellectual property portfolio covering our swallowable, gas-filled intragastric balloon system in the U.S.,” said
President & Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.